Close Menu

Quidel

The clearance is the fourth for a Quidel test on the AmpliVue handheld MDx format.

The company announced its plans for a public offering of the notes last week to fund working capital and general corporate purposes.

Quidel announced the pricing of its previously announced underwritten public offering of $150 million in convertible senior notes.

Quidel will use the net proceeds from the offering for working capital and other general corporate purposes.

NEW YORK (GenomeWeb) — In an effort to design primers that might solve the conundrum of the plateau effect in PCR amplification, researchers at Ohio State University and Ilia State University in the country of Georgia have created a method called quadruplex priming amplification.

This article has been updated from a previous version to include comments from Quidel's Q3 earnings call.

NEW YORK (GenomeWeb) – Quidel has received US Food and Drug Administration 510(k) clearance for its human parainfluenza virus molecular diagnostic test, the firm said today.

NEW YORK (GenomeWeb) — Quidel said on Monday that it has received 510(k) clearance from the US Food and Drug Administration to market its Lyra Adenovirus Assay, a real-time PCR test for the qualitative detection of human adenovirus viral DNA from nasal and nasopharyngeal swabs.

NEW YORK (GenomeWeb) — In cases where US Food and Drug Administration-cleared assays do not exist, clinicians often use their own lab-developed PCR assays to test for conditions of interest. This process can involve separate extraction and amplification steps, and extensive hands-on time.

NEW YORK (GenomeWeb) — Researchers at Johns Hopkins University have performed the first validation of the Cepheid Xpert Flu assay in a population of emergency room patients with acute undifferentiated respiratory illness.

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.